Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
kidney cancer
Pharma
BMS touts latest Opdivo data as I-O battle heads to new front
BMS said it will discuss the subcutaneous Opdivo data with regulators to potentially get the new version approved “across multiple indications.”
Angus Liu
Jan 29, 2024 8:45am
Merck celebrates trial win, while Bristol fails in kidney cancer
Jan 27, 2024 10:00am
FDA signs off on 2nd approval for Merck's Welireg
Dec 15, 2023 11:33am
At ESMO, Merck touts Welireg's potential in kidney cancer
Oct 21, 2023 9:00am
AZ agrees to $425M settlement in US over heartburn drugs
Oct 3, 2023 10:57am
ASCO: Merck's Keytruda, Roche's Tecentriq add to I-O failures
Jun 6, 2023 8:19am